Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
- Status
- COMPLETED
- Phase
- NA
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
- Status
- COMPLETED
- Phase
- N/A
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- NA
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)
- Status
- TERMINATED
- Phase
- PHASE2
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1